CHICAGO (PRWEB) December 12, 2018

LiveMed Media announced today the latest release of the Medeligo® oncology search app. Access to the most up-to-date clinical information is a constant challenge for clinicians, especially given the rapidly changing landscape in cancer treatment. The Medeligo® release provides an efficient, comprehensive platform to instantly get any available oncology information to assist in the treatment and management of all types of cancer.

Medeligo® allows clinicians to quickly and easily find critical oncology information and this release completes access to all subspecialties including brain, breast, colorectal, gastrointestinal, genitourinary, gynecologic, hematology, lung, pancreas, and skin. Medeligo® has made getting information easy through a series of curated tailored questions for each subspecialty. The app also allows the user to create and bookmark customized questions and create an online library of frequently referenced articles.

“We are excited about the completion of the latest version of Medeligo®” stated John Ruge, MD, FAANS, founder of LiveMed Media. “Putting oncology information into the hands of front-line clinicians ensures we have the most current evidence-based treatment information when treating our patients in their battle against cancer.”

Medeligo® is currently available on the App Store.

About LiveMed Media and Medeligo®
Medeligo® is the brainchild of neurosurgeon John Ruge, MD, FAANS. His frustration with existing mobile options to quickly and easily find critical neurosurgical information led to the founding of LiveMed Media and the subsequent development of Medeligo® – an oncology search app. Medeligo® was developed with the help of professional medical librarians and information specialists, and the creation of proprietary technology, to provide a fast, easy, yet powerful method of searching for highly-targeted oncology information. LiveMed Media’s vision is to transform the way physicians access medical information, ultimately leading to a new standard in medical education and practice that is easily accessible to all. Learn more about Medeligo® at

View pdf of the press release.